Skip to main content

Eloxatin FDA Approval History

FDA Approved: Yes (First approved August 9, 2002)
Brand name: Eloxatin
Generic name: oxaliplatin
Dosage form: Injection
Company: Sanofi-Synthelabo
Treatment for: Colorectal Cancer

Eloxatin (oxaliplatin injection) platinum-based drug used in combination with infusional 5-fluorouracil /leucovorin for the treatment of advanced carcinoma of the colon or rectum.

Development timeline for Eloxatin

Jan 31, 2005Approval Sanofi-aventis Receives FDA Approval for New Eloxatin Formulation

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.